KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Enterprise Value (2016 - 2025)

Exact Sciences (EXAS) has disclosed Enterprise Value for 16 consecutive years, with -$964.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 7.06% to -$964.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$964.7 million, a 7.06% increase, with the full-year FY2025 number at -$964.7 million, up 7.06% from a year prior.
  • Enterprise Value was -$964.7 million for Q4 2025 at Exact Sciences, up from -$1.0 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$632.1 million in Q4 2022 to a low of -$1.4 billion in Q1 2021.
  • A 5-year average of -$901.9 million and a median of -$837.7 million in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: surged 45.09% in 2022, then crashed 39.04% in 2024.
  • Exact Sciences' Enterprise Value stood at -$1.0 billion in 2021, then soared by 38.66% to -$632.1 million in 2022, then decreased by 23.03% to -$777.6 million in 2023, then crashed by 33.48% to -$1.0 billion in 2024, then rose by 7.06% to -$964.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Enterprise Value are -$964.7 million (Q4 2025), -$1.0 billion (Q3 2025), and -$858.4 million (Q2 2025).